Forge And Basilea Enter Into Multi-Target Agreement To Discover And Develop Novel Antibiotics
San Diego, California, April 24, 2019 – Forge Therapeutics, Inc. [...]
Fighting the dangerous increase of multi drug-resistant Microbes
In 1928, Alexander Fleming discovered penicillin, which would become the [...]
New partnership to tackle threat of superbugs
West Coast, USA-based Forge Therapeutics has inked a deal with [...]
Forge Therapeutics, Basilea Pharmaceutica partner on antibiotics
San Diego’s Forge Therapeutics has partnered with Basilea Pharmaceutica to [...]
Forge Therapeutics, Basilea Sign Deal to Pursue New Antibiotics
Forge Therapeutics, founded in 2015 with the goal of developing [...]
Forge Therapeutics to present at the 18th Annual Needham & Company Healthcare Conference
-Presentation will focus on Forge’s novel chemistry platform, BLACKSMITH, and [...]
Forge Therapeutics Gets up to $11.1M to Advance “Superbug” Drugs
As strains of bacteria evolve to fight back against common [...]
Forge Receives Second CARB-X Award For Up To $11.1M To Accelerate Development Of Novel Antibiotic To Treat Lung Infections
San Diego, California, January 3, 2019 – Forge Therapeutics, Inc. [...]